| Eugenia Ann Dabney Hofammann, MA, LMHC | |
|
1150 5th St Ste 270, Coralville, IA 52241-2933 | |
| (319) 804-9312 | |
| (319) 449-3845 |
| Full Name | Eugenia Ann Dabney Hofammann |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1150 5th St Ste 270, Coralville, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417591785 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 096331 (Iowa) | Primary |
| Entity Name | Meadowlark Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023141330 PECOS PAC ID: 8921331836 Enrollment ID: O20190607002380 |
News Archive
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Researchers in the UK and Austria have identified a novel class of antibodies that is highly effective at neutralizing the original strain of severe acute respiratory syndrome (SARS-CoV-2) and maintaining blocking activity against certain viral variants that have emerged.
A group of cardiologists is changing the conversation about a form of heart disease and exercise. One patient details how she's maintaining an active lifestyle while minimizing risk.
On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugenia Ann Dabney Hofammann, MA, LMHC 1150 5th St Ste 270, Coralville, IA 52241-2933 Ph: () - | Eugenia Ann Dabney Hofammann, MA, LMHC 1150 5th St Ste 270, Coralville, IA 52241-2933 Ph: (319) 804-9312 |
News Archive
Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.
Researchers in the UK and Austria have identified a novel class of antibodies that is highly effective at neutralizing the original strain of severe acute respiratory syndrome (SARS-CoV-2) and maintaining blocking activity against certain viral variants that have emerged.
A group of cardiologists is changing the conversation about a form of heart disease and exercise. One patient details how she's maintaining an active lifestyle while minimizing risk.
On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.
› Verified 8 days ago
Lydia Mossman, LISW Counselor Medicare: Accepting Medicare Assignments Practice Location: 2055 Oakdale Rd, Coralville, IA 52241 Phone: 319-338-1324 Fax: 319-338-2866 | |
Ms. Laura Cain-shreiner, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2240 9th St, Coralville, IA 52241 Phone: 563-209-2790 | |
Chantel Amani Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2140 Norcor Ave, Coralville, IA 52241 Phone: 319-975-8705 | |
Christina Sowers, Counselor Medicare: Not Enrolled in Medicare Practice Location: 520 10th Ave Ste B37, Coralville, IA 52241 Phone: 319-688-3402 | |
Susan M Woolever, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 412 6th Ave Apt 12, Coralville, IA 52241 Phone: 312-363-8142 | |
Kristine Taylor, LMHC Counselor Medicare: Medicare Enrolled Practice Location: 1150 5th St Ste 270, Coralville, IA 52241 Phone: 319-804-9312 Fax: 319-449-3845 |